Literature DB >> 30659440

Timing and Outcomes of Abdominal Surgery in Neutropenic Patients.

Joshua S Jolissaint1, Maya Harary2, Lily V Saadat3, Arin L Madenci3, Bryan V Dieffenbach3, Riad H Al Natour4, Ali Tavakkoli3,2,5.   

Abstract

BACKGROUND: Surgery in neutropenic patients is challenging due to both atypical manifestations of common conditions and higher perioperative risk. We sought to describe the outcomes of neutropenic patients undergoing abdominal surgery and to identify factors contributing to morbidity and mortality.
METHODS: A retrospective chart review was performed for all patients neutropenic in the 24-hours prior to an abdominal operation at our institution between 1998 and 2017. The primary and secondary outcomes were 30-day mortality and morbidity, respectively. The chi-square test and two-tailed Student's t test were used for univariable comparisons (non-parametric tests used when appropriate). To determine the optimal threshold of absolute neutrophil count (ANC) to discriminate 30-day mortality, we maximized the Youden index (J).
RESULTS: Amongst 237 patients, mortality was 11.8% (28/237) and morbidity 54.5% (130/237). Absolute neutrophil count < 500 cells/μL (50% vs. 20.6%, P < 0.01) and perforated viscus (35.7% vs. 14.8%, P = 0.01) were associated with mortality. Perforated viscus (25.4% vs. 7.5%) was also associated with morbidity. Urgent operations were associated with higher morbidity (63.6% vs 34.7%, P < 0.001) and mortality (16.4% vs 1.4%, P = 0.002) when compared to elective operations. Transfer from an outside hospital (22.3% vs. 11.2%, P = 0.02) and longer median time from admission to operation (2 days (IQR 0-6) vs. 1 day (IQR 0-3), P < 0.01) were associated with morbidity. An ANC threshold of 350 provided the best discrimination for mortality.
CONCLUSIONS: Elective surgery in the appropriately chosen neutropenic patient is relatively safe. For patients with obvious surgical pathology, we advocate for earlier operation and a lower threshold for surgical consultation in an effort expedite the diagnosis and necessary treatment.

Entities:  

Keywords:  General surgery; Neutropenia; Outcomes research

Mesh:

Year:  2019        PMID: 30659440     DOI: 10.1007/s11605-018-04081-0

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  23 in total

Review 1.  Neutrophils and immunity: challenges and opportunities.

Authors:  Carl Nathan
Journal:  Nat Rev Immunol       Date:  2006-03       Impact factor: 53.106

2.  Understanding neutropenia.

Authors:  David C Dale
Journal:  Curr Opin Hematol       Date:  2014-01       Impact factor: 3.284

Review 3.  Management of neutropenia in cancer patients.

Authors:  Maryam B Lustberg
Journal:  Clin Adv Hematol Oncol       Date:  2012-12

4.  Abdominal pain in neutropenic patients.

Authors:  D S Wade; H Douglass; H R Nava; M Piedmonte
Journal:  Arch Surg       Date:  1990-09

5.  Determinants of long-term survival after major surgery and the adverse effect of postoperative complications.

Authors:  Shukri F Khuri; William G Henderson; Ralph G DePalma; Cecilia Mosca; Nancy A Healey; Dharam J Kumbhani
Journal:  Ann Surg       Date:  2005-09       Impact factor: 12.969

6.  Impact of advancing age on abdominal surgical outcomes.

Authors:  Nader N Massarweh; Victor J Legner; Rebecca G Symons; Wayne C McCormick; David R Flum
Journal:  Arch Surg       Date:  2009-12

7.  Perioperative recombinant human granulocyte colony-stimulating factor (Filgrastim) treatment prevents immunoinflammatory dysfunction associated with major surgery.

Authors:  Christian Schneider; Sonja von Aulock; Siegfried Zedler; Christian Schinkel; Thomas Hartung; Eugen Faist
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

8.  Challenges in surgical management of abdominal pain in the neutropenic cancer patient.

Authors:  Brian D Badgwell; Janice N Cormier; Curtis J Wray; Gautam Borthakur; Wei Qiao; Kenneth V Rolston; Raphael E Pollock
Journal:  Ann Surg       Date:  2008-07       Impact factor: 12.969

9.  Incidence of chemotherapy-induced neutropenia and current practice of prophylaxis with granulocyte colony-stimulating factors in cancer patients in Spain: a prospective, observational study.

Authors:  L Jolis; F Carabantes; S Pernas; B Cantos; A López; P Torres; C Funes; D Caballero; P Benedit; A Salar
Journal:  Eur J Cancer Care (Engl)       Date:  2013-06-03       Impact factor: 2.520

10.  Perioperative granulocyte colony-stimulating factor does not prevent severe infections in patients undergoing esophagectomy for esophageal cancer: a randomized placebo-controlled clinical trial.

Authors:  Hartmut Schaefer; Andreas Engert; Guido Grass; Georg Mansmann; Gernot Wassmer; Kai Hubel; Dietrich Loehlein; Bernward C Ulrich; Hans Lippert; Wolfram T Knoefel; Arnulf H Hoelscher
Journal:  Ann Surg       Date:  2004-07       Impact factor: 12.969

View more
  5 in total

1.  Pyomyositis presenting as myonecrosis secondary to methicillin-resistant Staphylococcus aureus bacteremia in chronic lymphocytic leukemia.

Authors:  Shannon Coombs; Albert Bui; Haares S Mirzan; Kimberly Robelin; Hillary W Garner; Murli Krishna; Jennifer B Cowart
Journal:  Proc (Bayl Univ Med Cent)       Date:  2022-05-31

Review 2.  Gastrointestinal Surgical Emergencies in the Neutropenic Immunocompromised Patient.

Authors:  Michael G White; Ryan B Morgan; Michael W Drazer; Oliver S Eng
Journal:  J Gastrointest Surg       Date:  2021-09-10       Impact factor: 3.452

3.  Combination of Common Problem in a Rare Disease: Right Iliac Fossa Pain in a Chronic Myeloid Leukemia Patient.

Authors:  Ahmed Faidh Ramzee; Mohammad Sameer; Mohammad Burhan Khan; Syed Muhammad Ali; Ahmad Zarour
Journal:  Cureus       Date:  2020-11-17

Review 4.  Current Perspectives on Spinal Cord Stimulation for the Treatment of Cancer Pain.

Authors:  Jonathan M Hagedorn; Thomas P Pittelkow; Christine L Hunt; Ryan S D'Souza; Tim J Lamer
Journal:  J Pain Res       Date:  2020-12-07       Impact factor: 3.133

5.  Rare complication of inflammatory bowel disease-like colitis from glycogen storage disease type 1b and its surgical management: A case report.

Authors:  Frederick Chi-Wai Lui; Oswens Siu-Hung Lo
Journal:  World J Clin Cases       Date:  2021-06-06       Impact factor: 1.337

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.